Global Artificial Intelligence Platforms Market (2020 to 2024) - Featuring Palantir Technologies, Salesforce & SAP Among Others - ResearchAndMarkets.com

·3-min read

The "Global Artificial Intelligence Platforms Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

The artificial intelligence platforms market is poised to grow by $ 12.51 bn during 2020-2024 progressing at a CAGR of 33% during the forecast period.

Our reports on artificial intelligence platforms market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven Rise in demand for AI-based solutions. In addition, Rise in demand for AI-based solutions is anticipated to boost the growth of the market as well.

This study identifies investments in ai start-ups as one of the prime reasons driving the artificial intelligence platforms market growth during the next few years. investments in ai start-ups will lead to sizable demand in the market.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The artificial intelligence platforms market covers the following areas:

  • Artificial intelligence platforms market sizing

  • Artificial intelligence platforms market forecast

  • Artificial intelligence platforms market industry analysis

Companies Mentioned

  • Alibaba Group Holding Ltd.

  • Alphabet Inc.

  • Amazon Web Services Inc.

  • International Business Machines Corp.

  • Microsoft Corp.

  • Palantir Technologies Inc.

  • Salesforce.com Inc.

  • SAP SE

  • SAS Institute Inc.

  • Tata Consultancy Services Ltd.

Key Topics Covered:

1. Executive Summary

  • Market Overview

2. Market Landscape

  • Market ecosystem

  • Value chain analysis

3. Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2019

  • Market outlook: Forecast for 2019 - 2024

4. Five Forces Analysis

  • Five forces summary

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

5. Market Segmentation by Deployment

  • Market segments

  • Comparison by Deployment

  • On-premise - Market size and forecast 2019-2024

  • Cloud-based - Market size and forecast 2019-2024

  • Market opportunity by Deployment

6. Customer landscape

7. Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2019-2024

  • APAC - Market size and forecast 2019-2024

  • Europe - Market size and forecast 2019-2024

  • South America - Market size and forecast 2019-2024

  • MEA - Market size and forecast 2019-2024

  • Key leading countries

  • Market opportunity by geography

  • Market drivers - Demand led growth

  • Market challenges

  • Market trends

8. Vendor Landscape

  • Vendor landscape

  • Landscape disruption

9. Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • Alibaba Group Holding Ltd.

  • Alphabet Inc.

  • Amazon Web Services Inc.

  • International Business Machines Corp.

  • Microsoft Corp.

  • Palantir Technologies Inc.

  • Salesforce.com Inc.

  • SAP SE

  • SAS Institute Inc.

  • Tata Consultancy Services Ltd.

10. Appendix

  • Scope of the report

  • Currency conversion rates for US$

  • Research methodology

  • List of abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/yv1y99

View source version on businesswire.com: https://www.businesswire.com/news/home/20200810005571/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Latest stories

  • Ice flies African asylum seekers to Nairobi in last-minute deportation push

    Ice flies African asylum seekers to Nairobi in last-minute deportation push. Immigration and Customs Enforcement has stepped up removals of Africans and could send a final flight on Tuesday

  • UK Coronavirus LIVE: New Brazilian variant ‘likely’ already in the UK as Keir Starmer suggests stronger lockdown

    The highly-infectious new Brazilian variant of coronavirus is likely to already be in the UK, a Government scientist has warned. While the UK  is set to face short-term delays in delivery of the Pfizer coronavirus vaccine as the pharmaceutical company upgrades its production capacity, it has been announced. It comes as the UK's aviation sector says it will need "urgent" government support if it is to survive another long period of travel curb, after the UK announced all travel corridors will be suspended from 4am on Monday.

  • Trump news - President wants ‘military’ sendoff as top Democrat says ex-staff cannot salvage reputations

    All the latest from the White House and beyond on 16 January 2021

  • Britain will be able to vaccinate nation against new Covid strains within months after new super-factory opens

    Britain will be able to vaccinate the entire nation against dangerous new Covid strains within four months after a £158m super-factory opens later this year, The Telegraph can disclose. Dr Matthew Duchars, chief executive of the Vaccines Manufacturing Innovation Centre (VMIC), revealed the Oxfordshire facility will be capable of producing 70m doses of an emergency vaccine manufactured entirely on British soil. The news comes amid fears that a new Covid strain from Brazil may prove resistant to current vaccines. All travel corridors into the UK were scrapped this week to prevent new variants entering the country. “We’ll be able to make 70 million doses within a four to five month period, enough for everyone in the country, when we open late this year,” Dr Duchars told The Telegraph. “New Covid variants are absolutely part of the thinking. We probably will need to make seasonal vaccine variants because there may well be mutations in the virus, as well as vaccines for other diseases. You never know what’s coming next.” Currently under construction at the Harwell Science & Innovation Campus in Oxfordshire, the VMIC was first conceived in 2018 and originally planned to open in 2022. When the Covid pandemic struck, the UK government pumped a further £131 million into the not-for-profit company to bring the project forward by a year. The centre is already helping to manufacture the Oxford vaccine by lending expertise and giant bioreactors to the AstraZeneca team and its partners. This week Sir Mene Pangalos, executive vice president of biopharmaceuticals research and development at AstraZeneca, told MPs that the UK’s lack of manufacturing capacity had been a major stumbling block in the development of the Oxford vaccine, and urged ministers to “urgently address” the issue. Much of the Pfizer and Oxford vaccine doses currently being rolled out in the UK are made in factories in Belgium and the Netherlands. Dr Duchars said the VMIC would be equipped to produce different types of vaccines including MRNA varieties like the Pfizer jab and adenovirus-based technology like the Oxford AstraZeneca jab. “Covid came a year early for us, unfortunately,” he said. “But when we open we’ll have a sovereign capability to manufacture different types of vaccines and still be able to make a large number of doses. “It is a challenge. But that's what we're shooting for. If you don't set yourself a tough target, then there's no chance you can reach it.” He added how the company and its new super-factory could also be used to help developers of numerous other vaccines - not just those targeting Covid-19 - from private and public organisations, whether academic institutions or foundations or private laboratories. Explaining how he believes it is “absolutely remarkable” the vaccine has been developed so quickly, he said: “We may not have a facility that's built and ready to go. But we do have people who understand how to develop and manufacture vaccines. “So, we've essentially lent them out to organisations to help them with the scale up and manufacturer of COVID-19 vaccine.” “And we've been working with lots of those different organisations to help really accelerate and speed up and provide surety and expertise around how to get this vaccine made quickly.” He said the new centre is “technology agnostic”, meaning it can be adapted to different methods for different types of vaccine and viruses. “What we didn't want to do was make a facility that would be great for making the AstraZeneca vaccine, for example, but then next year a different MERS [Middle East Respiratory Syndrome] or SARS [Severe Acute Respiratory Syndrome] comes along.” he added. “That's a different type of platform and a different vaccine. So we've got to have a flexible facility that is able to make in an emergency a large amount of doses from different types of processes.”

  • Doctors told to bin leftover vaccines instead of administering second doses

    GPs have reportedly been warned by local health authorities that they cannot use extra doses on staff or any patients who have already received their first jab.

  • Forty seven players quarantined after COVID-19 cases on Australian Open flights

    Forty-seven players have been forced into two weeks of hotel quarantine in Melbourne after three coronavirus infections were reported on two chartered flights carrying them to the year's first grand slam, the tournament organisers said on Saturday. Two dozen players who arrived from Los Angeles entered strict hotel quarantine after an aircrew member and Australian Open participant who is not a player tested positive for the new coronavirus. Later, another non-player passenger on a flight from Abu Dhabi tested positive, prompting the organisers to usher 23 players into hotel quarantine.

  • Britain could have more Covid-19 variants as population has greater immunity, Sage scientist suggests

    Britain could experience more Covid-19 variants than other countries because a greater proportion of the population has built up immunity, a Sage scientist has suggested. Prof John Edmunds, a member of the government's Scientific Advisory Group for Emergencies from the London School of Hygiene and Tropical Medicine, said the virus tends to mutate in areas where many people have had it. The South African and Brazilian variants emerged among populations who had already developed some resistance to the virus, he said, and it may be evolving in order to "evade the immune response". "In parts of South Africa where the South African variant arose, there was probably quite a high level of immunity in the population at the time," said Prof Edmunds. "That's also true of the Brazilian variant that we're really concerned about. There's good data to suggest that in Manaus there was high levels of immunity at the time it arose." The South African variant was first spotted in Britain in December. There are two Brazilian variants. One – known as P.1 – was detected circulating in Manaus, northern Brazil, by scientists in December. This is the one the government is most concerned about. A second one - known as P.2. - has been spotted 11 times in Britain and carries a mutation which can bypass antibodies.

  • Kayleigh McEnany leaves White House after final two-minute press briefing following deadly Capitol riot

    Trump’s press secretary refused to take questions following the deadly insurrection at the US Capitol earlier this month

  • Covid news – live: Johnson under pressure over inquiry as doctors face choosing patients to prioritise

    Follow the latest updates on the pandemic

  • All over 18s could have vaccine by 'end of June'

    Every adult in Britain will be vaccinated by the end of June, senior Government figures hope, as they grow increasingly optimistic they will be able to accelerate the rollout. The Telegraph can reveal Whitehall sources believe this target could now realistically be achieved as they plan to vaccinate four to five million people a week within months. A further two vaccines in the pipeline, from Moderna and Johnson & Johnson, could help Britain speed up the process to vaccinate all 54 million adults. A source said: "All over-18s by June – yes." They added: "It is delivery, delivery, delivery.” While senior Government figures are now privately working to this target, the Department of Health – which said it hoped to have vaccinated "tens of millions" of Britons by April – are reluctant to publicly acknowledge a deadline. Separately, the chief executive of Britain's new £158 million Government vaccine factory in Oxfordshire told The Telegraph it will be able to vaccinate the entire nation against dangerous new Covid strains within four months when it opens in full by the end of the year.

  • Uganda presidential election: Incumbent Yoweri Museveni declared winner

    Yoweri Museveni has been declared the winner of the Uganda presidential election with 58.64% of the total votes, according to the country's electoral commission.

  • Son of Only Fools and Horses actor Nicholas Lyndhurst died of rare brain condition, his family reveal

    The mother of teenage actor Archie Lyndhurst has revealed  he died from a brain haemorrhage while he slept at his family home in west London. The teenager, who had been acting since the age of 11 and was son of Only Fools and Horses star Nicholas Lyndhurst, starred in the hit CBBC show So Awkward as Ollie Coulton and was dating co-star Nethra Tilakumara. Archie had no signs of illness before his death his family said.

  • The Masked Singer: Full list of odds for who’s behind each costume

    *Spoilers for this week’s episode of The Masked Singer below*

  • Donald Trump isolated and enraged ahead of Biden inauguration

    Donald Trump isolated and enraged ahead of Biden inauguration. A slew of aides have deserted the president and the Pentagon has decided not to hold an armed forces farewell tribute

  • Dancing On Ice's Colin Jackson Explains Why He Turned Down Same-Sex Partnership

    The former Olympic hurdler is paired with professional skater Klabera Komini.

  • Wuhan lab staff were first victims or coronavirus, says US

    The US claimed on Saturday that staff at a Chinese virology laboratory became sick with a Covid-like illness in autumn 2019, months before the coronavirus spread widely from Wuhan. In a long-awaited document from the state department, the Trump administration called for an investigation as it published dubious accusations that a possible "laboratory accident" at the Wuhan Institute of Virology (WIV) may be the source of the global pandemic. The claims were dismissed by analysts who insist the disease came from a naturally occurring event. In a statement late on Friday claiming to reveal "undisclosed information", the state department said it "has reason to believe that several researchers inside the WIV became sick in autumn 2019, before the first identified case, with symptoms consistent with both Covid-19 and common seasonal illnesses." The statement also said that the lab had been carrying out research on a bat coronavirus similar to the Sars-CoV-2 strain that spread globally and that the lab had collaborated with China's military on publications and secret projects. Some experts were nonplussed by the announcement. "Zero details given," noted Kristian Andersen, an immunologist at Scripps Research, rating the statement as "an F". The fact that Wuhan was home to the world's leading coronavirus research facility before it became known as ground zero for the pandemic has led to speculation that the virus could have originated in the lab.

  • Leaving WhatsApp will be hard – but it is the right thing to do

    Last week, WhatsApp sent a message to all of its users informing them of its new privacy policy, which would share data from the messaging app to Facebook – Elon Musk has a point when he tells us to ‘use Signal’

  • China builds 1,500-bed hospital in five days amid surge in Covid cases

    Total of 645 people being treated in Nangong and Hebei provincial capital, Shijiazhuang, Xinhua reports

  • US Health secretary Azar warns Capitol riots have threatened Trump’s legacy in resignation letter

    ‘The attacks on the Capitol were an assault on our democracy’

  • Global report: coronavirus death toll reaches 2 million

    Global report: coronavirus death toll reaches 2 million. ‘Heart-wrenching milestone’ says UN chief; China reports 130 new cases in flare-up; India starts mass vaccination campaign